The University of Chicago Header Logo

Connection

Gladell P. Paner to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications Gladell P. Paner has written about Xenograft Model Antitumor Assays.
  1. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
    View in: PubMed
    Score: 0.031
  2. Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells. Clin Cancer Res. 2011 May 15; 17(10):3112-22.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.